Kenta Nakamura
10PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jun 19, 2024
Tumor eradication by triplet therapy with BRAF inhibitor, TLR 7 agonist, and PD-1 antibody for BRAF-mutated melanoma.Kenta Nakamura, Tomonori Yaguchi, Masashi Murata
|Dec 21, 2022
Analysis of immune-related adverse events correlated with good prognosis in melanoma treatment and fluctuating blood factors.Kenta Nakamura, Atsuko Ashida, Yukiko Kiniwa
|Nov 22, 2022
Immune status and prognosis of stage II and III primary malignant melanoma: An analysis including 77 cases of acral lentiginous melanoma.Kenta Nakamura, Atsuko Ashida, Yukiko Kiniwa
|Nov 11, 2022
Changes in the Immune Cell Repertoire for the Treatment of Malignant Melanoma.Kenta Nakamura, Ryuhei Okuyama
|Nov 29, 2021
Chemokine level predicts the therapeutic effect of anti-PD-1 antibody (nivolumab) therapy for malignant melanoma.Kenta Nakamura, Atsuko Ashida, Yukiko Kiniwa
|Sep 21, 2021
Case of bullous pemphigoid following coronavirus disease 2019 vaccination.Kenta Nakamura, Megumi Kosano, Yuzuki Sakai
Pageof 2
